Petra Lukacik

3.6k total citations
34 papers, 1.7k citations indexed

About

Petra Lukacik is a scholar working on Molecular Biology, Computational Theory and Mathematics and Genetics. According to data from OpenAlex, Petra Lukacik has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Computational Theory and Mathematics and 9 papers in Genetics. Recurrent topics in Petra Lukacik's work include Computational Drug Discovery Methods (10 papers), Bacterial Genetics and Biotechnology (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Petra Lukacik is often cited by papers focused on Computational Drug Discovery Methods (10 papers), Bacterial Genetics and Biotechnology (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Petra Lukacik collaborates with scholars based in United Kingdom, United States and Australia. Petra Lukacik's co-authors include Susan K. Buchanan, Udo Oppermann, K.L. Kavanagh, Travis J. Barnard, Nicholas Noinaj, N. Easley, Trevor Lithgow, James C. Gumbart, Adam J. Kuszak and Martin Walsh and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Petra Lukacik

33 papers receiving 1.6k citations

Peers

Countries citing papers authored by Petra Lukacik

Since Specialization

Citations

This map shows the geographic impact of Petra Lukacik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Lukacik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Lukacik more than expected).

Fields of papers citing papers by Petra Lukacik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Lukacik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Lukacik. The network helps show where Petra Lukacik may publish in the future.

Co-authorship network of co-authors of Petra Lukacik

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Lukacik. A scholar is included among the top collaborators of Petra Lukacik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Lukacik. Petra Lukacik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies 2025 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Stephen M. Laidlaw, E. Salah, (unknown), Petra Lukacik, Hani Choudhry, Martin Walsh, Miles W. Carroll, Christopher J. Schofield, Lennart Brewitz	0
2	Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease 2024 ·Bulletin of the Chemical Society of Japan ·Takashi Miura, Tika R. Malla, Lennart Brewitz, Anthony Tumber, E. Salah, KangJu Lee, Naohiro Terasaka, David Owen, Claire Strain‐Damerell, Petra Lukacik, Martin Walsh, Akane Kawamura, Christopher J. Schofield, Takayuki Katoh, Hiroaki Suga	12
3	Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein 2023 ·RSC Chemical Biology ·(unknown), Lennart Brewitz, Petra Lukacik, Claire Strain‐Damerell, Martin Walsh, Christopher J. Schofield, Fernanda Duarte	5
4	Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine 2023 ·Journal of Medicinal Chemistry ·Lennart Brewitz, (unknown), (unknown), David Owen, Stephen M. Laidlaw, Tika R. Malla, Dung Nguyen, Petra Lukacik, E. Salah, (unknown), Anna J. Warren, José Trincão, Claire Strain‐Damerell, Miles W. Carroll, Martin Walsh, Christopher J. Schofield	38
5	AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity In Vitro 2023 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), (unknown), Rafael Ferreira Dantas, Mário Roberto Senger, (unknown), (unknown), (unknown), (unknown), Milene Dias Miranda, Petra Lukacik, Claire Strain‐Damerell, David Owen, Martin Walsh, Sabrina Baptista Ferreira, Floriano Paes Silva	12
6	In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease 2023 ·Nature Chemistry ·Takashi Miura, Tika R. Malla, David Owen, Anthony Tumber, Lennart Brewitz, M.A. McDonough, E. Salah, Naohiro Terasaka, Takayuki Katoh, Petra Lukacik, Claire Strain‐Damerell, Halina Mikolajek, Martin Walsh, Akane Kawamura, Christopher J. Schofield, Hiroaki Suga	36
7	Accelerating drug target inhibitor discovery with a deep generative foundation model 2023 ·Science Advances ·Vijil Chenthamarakshan, Samuel C. Hoffman, David Owen, Petra Lukacik, Claire Strain‐Damerell, D. Fearon, Tika R. Malla, Anthony Tumber, Christopher J. Schofield, Helen M. E. Duyvesteyn, Wanwisa Dejnirattisai, Loïc Carrique, Thomas S. Walter, Gavin Screaton, (unknown), (unknown), Jason Crain, Martin Walsh, David I. Stuart, Payel Das	22
8	Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS‐CoV‐2 Papain‐Like Protease 2022 ·ChemMedChem ·Lennart Brewitz, Jos J. A. G. Kamps, Petra Lukacik, Claire Strain‐Damerell, (unknown), Anthony Tumber, Tika R. Malla, Allen M. Orville, Martin Walsh, Christopher J. Schofield	20
9	East Coast fever, a neglected tropical disease with an outdated vaccine approach? 2022 ·Trends in Parasitology ·(unknown), (unknown), Petra Lukacik, Mark Pfuhl, Dirk Werling	3
10	xia2.multiplex: a multi-crystal data-analysis pipeline 2022 ·Acta Crystallographica Section D Structural Biology ·Richard J. Gildea, James Beilsten‐Edmands, Danny Axford, Sam Horrell, Pierre Aller, James Sandy, Juan Sánchez-Weatherby, David Owen, Petra Lukacik, Claire Strain‐Damerell, Robin L. Owen, Martin Walsh, Graeme Winter	40
11	Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 M^pro inhibitors 2021 ·Chemical Communications ·Tika R. Malla, Anthony Tumber, Tobias John, Lennart Brewitz, Claire Strain‐Damerell, David Owen, Petra Lukacik, (unknown), (unknown), E. Salah, Fernanda Duarte, Haitao Yang, Zihe Rao, Martin Walsh, Christopher J. Schofield	32
12	The structure of nontypeable Haemophilus influenzae SapA in a closed conformation reveals a constricted ligand-binding cavity and a novel RNA binding motif 2021 ·PLoS ONE ·Petra Lukacik, David Owen, Gemma Harris, Jani Reddy Bolla, S. Picaud, (unknown), Joanne E. Nettleship, Louise E. Bird, Raymond J. Owens, Philip C. Biggin, P. Filippakopoulos, Carol V. Robinson, Martin Walsh	7
13	High-resolution structures ofLactobacillus salivariustransketolase in the presence and absence of thiamine pyrophosphate 2015 ·Acta Crystallographica Section F Structural Biology Communications ·Petra Lukacik, Carina M. C. Lobley, Mario Bumann, (unknown), Raymond J. Owens, Paul W. O’Toole, Martin Walsh	1
14	Using high-throughputin situplate screening to evaluate the effect of dehydration on protein crystals 2013 ·Acta Crystallographica Section D Biological Crystallography ·A. Douangamath, Pierre Aller, Petra Lukacik, Juan Sánchez-Weatherby, Isabel Moraes, J. Brandão-Neto	15
15	Structural engineering of a phage lysin that targets Gram-negative pathogens 2012 ·Proceedings of the National Academy of Sciences ·Petra Lukacik, Travis J. Barnard, Paul W. Keller, (unknown), Nabila Seddiki, J.W. Fairman, Nicholas Noinaj, Tara L. Kirby, Jeffrey P. Henderson, Alasdair C. Steven, B. Joseph Hinnebusch, Susan K. Buchanan	120
16	Structure–activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4 2008 ·Molecular and Cellular Endocrinology ·Wen‐Hwa Lee, Petra Lukacik, Kunde Guo, E. Ugochukwu, K.L. Kavanagh, Brian D. Marsden, Udo Oppermann	15
17	SDR-type human hydroxysteroid dehydrogenases involved in steroid hormone activation 2007 ·Molecular and Cellular Endocrinology ·Xiaoqiu Wu, Petra Lukacik, K.L. Kavanagh, Udo Oppermann	51
18	Autotransporter structure reveals intra-barrel cleavage followed by conformational changes 2007 ·Nature Structural & Molecular Biology ·Travis J. Barnard, Nathalie Dautin, Petra Lukacik, Harris D. Bernstein, Susan K. Buchanan	134
19	Structure and function of human 17β-hydroxysteroid dehydrogenases 2006 ·Molecular and Cellular Endocrinology ·Petra Lukacik, K.L. Kavanagh, Udo Oppermann	165
20	Characterization of Human DHRS6, an Orphan Short Chain Dehydrogenase/Reductase Enzyme 2005 ·Journal of Biological Chemistry ·Kunde Guo, Petra Lukacik, E. Papagrigoriou, Marc Meier, Wen‐Hwa Lee, Jerzy Adamski, Udo Oppermann	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact